SCHEMBL7475581

SCHEMBL7475581

CC(C)(C)OC(=O)N[C@H](CCc1ccc2ccccc2c1)C(=O)O

nearest known ligand 0.62

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
CTSK P43235 6/20 0.62
CTSS P25774 6/20 0.62
CTSB P07858 2/20 0.62
PTPN1 P18031 2/20 0.58
PPARA Q07869 7/20 0.54
PPARG P37231 6/20 0.54
ACE P12821 1/20 0.53
PPARD Q03181 2/20 0.52
GABRB1 P18505 1/20 0.48
GABRB2 P47870 1/20 0.48
TGM2 P21980 1/20 0.48
ITGB3 P05106 1/20 0.47
ITGA2B P08514 1/20 0.47
CTSL P07711 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8298606 1.00 CTSK (0.62) CTSKCTSSCTSBPTPN1PPARA
SCHEMBL17194109 0.89 PTPN1 (0.55) CTSKCTSSCTSBPTPN1PPARA
SCHEMBL15802510 0.89 PTPN1 (0.55) CTSKCTSSCTSBPTPN1PPARA
SCHEMBL29301853 0.88 CTSK (0.52) CTSKCTSSCTSBPTPN1PPARA
SCHEMBL29481445 0.88 CTSS (0.74) CTSKCTSSCTSBPTPN1PPARA
SCHEMBL29401906 0.88 CTSS (0.74) CTSKCTSSCTSBPTPN1PPARA
SCHEMBL3821361 0.88 CTSS (0.74) CTSKCTSSCTSBPTPN1PPARA
SCHEMBL29397962 0.88 CTSS (0.74) CTSKCTSSCTSBPTPN1PPARA
SCHEMBL29436862 0.88 CTSS (0.74) CTSKCTSSCTSBPTPN1PPARA
SCHEMBL1519731 0.88 CTSS (0.74) CTSKCTSSCTSBPTPN1PPARA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1937262-B1 COMPOSITION FOR USE IN TREATING GASTROINTESTINAL DYSMOTILITY IPSEN PHARMA (FR) 2019-05-08 EP disclosed
EP-0923550-B1 ACYLAMINOALKENYLENE-AMIDE DERIVATIVES AS NK1 AND NK2 ANTAGONISTS NOVARTIS AG (CH) 2002-09-25 EP disclosed
US-6319917-B1 NEUROGENIC INFLAMMATION AND TACHYKININ BRONCHOCONSTRICTION INHIBITORS NOVARTIS AG (CH) 2001-11-20 US disclosed